Connect Biopharmaceuticals Funding: $195M Raised, Series C

Connect Biopharmaceuticals is based in Suzhou, China. It has raised $195M in total funding. Latest round: Series C.

Connect Biopharmaceuticals funding overview

Connect Biopharmaceuticals is based in Suzhou, China. Connect Biopharmaceuticals has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2020. The round record for Connect Biopharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include RA Capital Management, Boxer Capital, HBM Healthcare Investment, Lilly Asia Ventures, Qiming Venture Partners. 5 distinct backers are named across the disclosed rounds.

Connect Biopharmaceuticals at a glance

Total raised
$195M
Latest round
Series C
Latest round date
August 2020
Headquarters
Suzhou, China
Notable investors
RA Capital Management, Boxer Capital, HBM Healthcare Investment, Lilly Asia Ventures, Qiming Venture Partners

Frequently asked about Connect Biopharmaceuticals funding

How much has Connect Biopharmaceuticals raised?
Connect Biopharmaceuticals has raised $195M in total disclosed funding across the rounds on record.
Who has invested in Connect Biopharmaceuticals?
RA Capital Management, Boxer Capital, HBM Healthcare Investment, Lilly Asia Ventures, Qiming Venture Partners are named among the investors backing Connect Biopharmaceuticals.
What was the latest Connect Biopharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in August 2020.
Where is Connect Biopharmaceuticals based?
Connect Biopharmaceuticals is based in Suzhou, China.
When did Connect Biopharmaceuticals last raise?
The last disclosed Connect Biopharmaceuticals round closed in August 2020 at Series C.

Every Connect Biopharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Suzhou at a similar stage.

Companies related to Connect Biopharmaceuticals (36)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades